儿童口腔高风险药物处方模式与不良结局分析
基于2014至2019年MarketScan数据,分析18岁以下有牙科就诊记录患者的处方。0.72%就诊涉及高风险药物,其中4.3%出现复合不良结局;涉及阿片类药物就诊中10.1%发生阿片相关结局。年幼儿童阿片相关结局比值比最高,提示需谨慎处方并遵循指南使用非阿片类镇痛。
要点
- 儿童牙科就诊中0.72%涉及高风险药物,复杂慢性病及医院/门诊手术环境风险更高。
- 涉及阿片类药物就诊中10.1%出现阿片相关结局,4-5岁儿童比值比最高。
- 应遵循指南使用非阿片类镇痛,加强处方者培训以促进安全公平处方。
核心结论
- 每10次涉及阿片类药物的儿童牙科就诊中约有1次与阿片相关过量或持续使用相关,年幼儿童比值比最高。
- 结果提示儿童阿片处方需谨慎,并应提供基于指南的非阿片类镇痛。
研究设计与样本
- 分析MarketScan数据库中2014年至2019年有牙科就诊的18岁以下患者数据。
- 高风险药物包括苯二氮䓬类、巴比妥类和阿片类;复合结局为就诊后7天内住院、急诊或 urgent care 就诊。
- 采用广义估计方程评估结局与患者及就诊特征的关联。
主要发现
- 牙科就诊中0.72%(n=269,991)涉及高风险药物,其中4.3%经历复合结局。
- 复合结局较高 odds 见于9-11岁(OR 1.56)、男性(OR 1.05)、复杂慢性病(OR 2.22)及医院或门诊手术环境(OR 2.20)。
- 涉及阿片类药物的牙科就诊中10.1%发生阿片相关结局,最高 odds 见于4-5岁(OR 1.48)、女性(OR 1.08)、复杂慢性病(OR 1.22)及门诊诊所(OR 1.43)。
临床怎么用
- 儿童牙科应谨慎处方阿片类药物,优先使用基于指南的非阿片类镇痛。
- 通过遵循指南、非阿片类疼痛管理和提供者培训促进更安全、公平的儿童牙科处方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-risk medications such as opioids and benzodiazepines are frequently prescribed in pediatric dental care, yet their prescribing patterns and associated adverse outcomes remain poorly understood. The aim of this study was to determine the extent of such prescribing to pediatric patients and factors associated with adverse outcomes. METHODS: MarketScan data for patients younger than 18 years with a dental visit from 2014 through 2019 were analyzed. High-risk medications included benzodiazepines, barbiturates, and opioids. Composite outcomes included hospitalization, emergency department visit, or urgent care visit within 7 days after the dental visit. Opioid-attributable outcomes included opioid-related overdose within 7 days or persistent opioid use 4 through 365 days after the visit. Generalized estimating equations assessed the association between outcomes and patient and visit characteristics. RESULTS: Among pediatric dental visits, 0.72% (n = 269,991) involved high-risk medications, with 4.3% experiencing a composite outcome. Higher odds were observed in ages 9 through 11 years (odds ratio [OR], 1.56), male patients (OR, 1.05), patients with complex chronic conditions (OR, 2.22), and care delivered in hospital or ambulatory surgery settings (OR, 2.20). Among dental visits with opioids, 10.1% had an opioid-attributable outcome, with the highest odds in patients 4 through 5 years (OR, 1.48), female patients (OR, 1.08), patients with complex chronic conditions (OR, 1.22), and care delivered in outpatient clinics (OR, 1.43). CONCLUSIONS: One in 10 pediatric dental visits involving opioids was associated with opioid-related overdose or persistent use, with the highest odds in young children. These results highlight the need for caution in opioid prescribing and providing guideline-based nonopioid analgesia to children. PRACTICAL IMPLICATIONS: Promote safer, equitable pediatric dental prescribing through guideline adherence, nonopioid pain management, and provider training.
引用
- Liu Y, Zouaidi K, Hubbard CC, et al. High-risk medications in pediatric dentistry: Patterns, outcomes, and clinical implications. J Am Dent Assoc. 2025. PMID: 41081662. doi:10.1016/j.adaj.2025.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。